Eye-stream Eye Wash Solution Recalled for Improper Storage
Mckesson Medical-Surgical has recalled Eye-stream eye wash solution nationwide due to storage conditions outside drug label specifications.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II designation indicates a potential risk-of-harm scenario. Improper storage of a sterile eye care product could compromise its sterility and safety. The source documents no reported illnesses or injuries, fitting the rubric criterion for Score 3: risk-of-harm products where injury has not yet been reported.
Plain-English summary
Eye-stream eye wash solution (4 FL OZ / 118 mL bottles, NDC 0065-0530-04) is being recalled nationwide. The recall affects 16 boxes of the product.
The recall was initiated because the product was stored outside the conditions specified on the drug label, constituting a Current Good Manufacturing Practice deviation. Improper storage of a sterile product could compromise its quality and safety.
This is a Class II recall. Consumers who have purchased this product should discontinue use and consult with their healthcare provider if they have questions or concerns about product exposure.
The recalled product
- Product
- Eye-stream, eye wash solution, sterile, 4 FL OZ (118 mL) bottle per box, Alcon, NDC 0065-0530-04.
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Eye Care / Ophthalmic
- Hazard
- improper-storage
- sterility-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Part# 0065053004
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27